Variant report
Variant | nsv582236 |
---|---|
Chromosome Location | chr2:76914970-76929044 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17013020 | chr2:76914970-76914971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72915624 | chr2:76914994-76914995 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs565984659 | chr2:76915012-76915013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536416382 | chr2:76915016-76915017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183357002 | chr2:76915024-76915025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576158724 | chr2:76915040-76915041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537140546 | chr2:76915071-76915072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs985812 | chr2:76915107-76915108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576748654 | chr2:76915113-76915114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185822114 | chr2:76915123-76915124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537214226 | chr2:76915134-76915135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35310640 | chr2:76915175-76915176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541049962 | chr2:76915180-76915181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560596988 | chr2:76915181-76915182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77006744 | chr2:76915191-76915192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs118030578 | chr2:76915203-76915204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574098361 | chr2:76915207-76915208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76468462 | chr2:76915267-76915268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531834576 | chr2:76915341-76915342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549843839 | chr2:76915346-76915347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565403227 | chr2:76915359-76915360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs954787 | chr2:76915366-76915367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs547783361 | chr2:76915367-76915368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565794010 | chr2:76915375-76915376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11689433 | chr2:76915391-76915392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116718250 | chr2:76915425-76915426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545563256 | chr2:76915429-76915430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150171850 | chr2:76915435-76915436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190585034 | chr2:76915487-76915488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183184888 | chr2:76915489-76915490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576894476 | chr2:76915501-76915502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138628389 | chr2:76915515-76915516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187890219 | chr2:76915570-76915571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs956733 | chr2:76915600-76915601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572359272 | chr2:76915613-76915614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192544219 | chr2:76915614-76915615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554887132 | chr2:76915633-76915634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576205546 | chr2:76915649-76915650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544013793 | chr2:76915697-76915698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565488500 | chr2:76915700-76915701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182411432 | chr2:76915707-76915708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187944846 | chr2:76915749-76915750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539008404 | chr2:76915754-76915755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192422259 | chr2:76915771-76915772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs954786 | chr2:76915788-76915789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79528007 | chr2:76915791-76915792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548488377 | chr2:76915800-76915801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553548704 | chr2:76915805-76915806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569994814 | chr2:76915813-76915814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530696550 | chr2:76915820-76915821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76906000-76926600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:76914200-76918200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:76914600-76915800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr2:76915800-76916000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr2:76916000-76927800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr2:76918200-76918600 | Strong transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:76918400-76919000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr2:76918600-76919000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:76918600-76919400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr2:76918600-76927600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:76918800-76919600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr2:76918800-76920200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:76922000-76922600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr2:76925600-76925800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr2:76926600-76926800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr2:76927800-76928400 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
17 | chr2:76928000-76928400 | Enhancers | Fetal Heart | heart |
18 | chr2:76928400-76934800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |